Rapid Dose Therapeutics veröffentlicht Update zum Nikotingeschäft und verlängert die Zusammenarbeit mit einem internationalem Nikotinpartner um sieben Monate.
Verfasser: pr-gateway on Tuesday, 21 October 2025
Rapid Dose Therapeutic erhält in diesem Zeitraum einen unterstützten Betrag von bis zu CAD 1,8 Millionen für weitere Kommerzialisierungsinitiativen für NicStrip™ .
Rapid Dose Therapeutics Releases Nicotine Business Update and Extends Collaboration with International Nicotine Partner
Seven-month extension valued at up to approximately $1.8 million CAD supports further evaluation as RDT advances broader commercialization initiatives for NicStrip™
Burlington, Ontario - October 20, 2025 - Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company developing innovative drug delivery solutions through its QuickStrip™ platform, today issued a comprehensive update on its nicotine strategy, including the extension of its exclusive pre-commercialization and development agreement (the “Agreement”) with its international nicotine partner.